February 27, 2023 | Written by Luke Perry

Emerging weight loss medications

Obesity is a major public health concern, as it is associated with numerous health problems, including type 2 diabetes, cardiovascular disease, and certain types of cancer. While lifestyle changes such as a healthy diet and exercise are recommended for weight loss, some individuals may benefit from medications that can aid in their weight loss journey. In recent years, there have been several new medications being used for weight loss, including tirzepatide, semaglutide, and dulaglutide.

Tirzepatide

Tirzepatide is a new medication that has shown promise in promoting weight loss. It is a once-weekly injection that combines three hormones - glucagon-like peptide-1 (GLP-1), gastric inhibitory peptide (GIP), and glucagon receptor agonist (GRA) - to help regulate appetite, glucose levels, and body weight. The medication has been shown to result in significant weight loss, with some clinical trials showing patients losing up to 20% of their initial body weight. In addition, it has been shown to improve glycemic control, blood pressure, and cholesterol levels.

Semaglutide

Semaglutide is another GLP-1 receptor agonist medication that has recently been approved for weight loss. It is a once-weekly injection that has been shown to result in significant weight loss, with some clinical trials showing patients losing up to 15% of their initial body weight. Semaglutide works by regulating appetite, reducing food intake, and promoting feelings of fullness. It has also been shown to improve glycemic control, blood pressure, and cholesterol levels.

Dulaglutide

Dulaglutide is another GLP-1 receptor agonist medication that has been used for the treatment of type 2 diabetes. It is a once-weekly injection that has been shown to result in modest weight loss, with some clinical trials showing patients losing up to 3% of their initial body weight. Dulaglutide works by regulating appetite, reducing food intake, and promoting feelings of fullness. It has also been shown to improve glycemic control, blood pressure, and cholesterol levels.

Comparing the Medications

While all three medications have been shown to result in weight loss, there are some differences between them. Tirzepatide has been shown to result in the greatest weight loss, with some clinical trials showing patients losing up to 20% of their initial body weight. Semaglutide has also been shown to result in significant weight loss, with some clinical trials showing patients losing up to 15% of their initial body weight. Dulaglutide has been shown to result in modest weight loss, with some clinical trials showing patients losing up to 3% of their initial body weight.

In addition, the medications have different dosing schedules. Tirzepatide is a once-weekly injection, while semaglutide is also a once-weekly injection. Dulaglutide is also a once-weekly injection, but it is typically used for the treatment of type 2 diabetes rather than weight loss specifically.

It is important to note that all three medications have potential side effects, including nausea, vomiting, diarrhea, and hypoglycemia. It is important to discuss any potential side effects with your healthcare provider.

Tirzepatide, semaglutide, and dulaglutide are new medications that have shown promise in promoting weight loss. While lifestyle changes such as a healthy diet and exercise are still recommended for weight loss, these medications may be useful for individuals who have struggled to lose weight through these methods alone.

Here at Reformr, we strongly believe that obesity is not a choice. We believe that obesity is a metabolic disease with a metabolic solution.

We are excited about the emerging therapeutic options in the area of evidence-based weight loss.

If you would like to find out if you might be eligible for Reformr’s metabolic reset programme, start by taking our eligibility quiz.